Science 37

By Jonah Comstock December 8, 2017
Otsuka Pharmaceuticals has deepened its relationship with Science 37, a startup it invested in earlier this year. Otsuka will use Science 37’s mobile clinical trial technology to further digitize its own trials, with an initial focus on psychiatry and behavioral health. “Otsuka is dedicated to promoting innovation in clinical trials as a means of expanding the diversity of patients enrolled in...
By Dave Muoio December 1, 2017
Editor's note: Since publication, some of this story's quotes have been edited for clarity. With billions of dollars and countless hours of human effort spent each year validating new drugs, devices, and medical interventions, it’s little surprise that the healthcare industry is turning to technology to streamline the process. From participant recruitment to data collection to adherence, clinical...
By Dave Muoio October 24, 2017
Los Angeles-based research company Science 37 announced the completion of a clinical study for AOBiome Therapeutics conducted entirely through a smartphone app. The Phase 2b study ran on the back of Science 37’s mobile Network Oriented Research Assistant (NORA) platform, which allows for real-time video chat, customized self-photography models, data collection, and electronic consent. Science 37...
By Heather Mack July 6, 2017
San Francisco-based Mendel.ai, a startup that is developing an artificial intelligence-powered platform to match people with cancer to clinical trials, has raised $2 million in seed funding from DCM Ventures, BootstrapLabs, Indie Bio, LaunchCapital and SOSV. Medel.ai will use the capital to forge partnerships with hospitals and cancer genomics companies to bring the system into use. For $99,...
By Jonah Comstock April 25, 2017
Remote clinical trial company Science 37 has raised $29 million in a round led by Glynn Capital Management with participation from Google's investment arm GV. One more new investor -- AmGen ventures -- contributed, as did existing investors Lux Capital, Redmile Group, dRx Capital, and Sanofi Ventures. It's a large round with impressive investors, but it is technically a down round from last fall'...
By Heather Mack October 18, 2016
Mobile clinical trials company Science 37, which connects willing individuals to researchers so they can participate in trials from their homes, has raised $31 million in Series B funding. Previously, the company raised $6.5 million. The round was led by Redmile Group, with participation from Lux Capital and Sanofi Genzyme BioVentures, the latter of which will also provide Science 37 with...
By Jonah Comstock June 13, 2016
Two of the biggest IPOs in digital health lately have come out of the wearable and telehealth spaces. But those aren't the spaces at least two seasoned digital health investors are most excited about. At BIO 2016 in San Francisco last week, Casper de Clerq, a general partner at Norwest Venture Partners, and Dr. Lucian Iancovici, a general partner at dRx Capital, Qualcomm and Novartis' joint...
By Jonah Comstock October 21, 2015
Los Angeles-based mobile clinical trials company Science 37 has raised $6.5 million from Lux Capital and dRx Capital, a joint venture of Qualcomm and Novartis that launched in January. The funding will help the company develop and roll out its novel clinical trial operating model, which uses mobile technology to allow patients to participate in the trial from their homes. The company draws on ...